Expanded Access to Medicine Policy
- July 9, 2024
Adopted by the Company on 09 July 2024
Serac Healthcare is dedicated to developing maraciclatide as a new molecular imaging agent that will have a positive impact on patient health, and to serving patients, patient families and patient communities through education, empathy, and awareness.
